This week's artwork was donated by Lonny, a pediatric cancer patient who received treatment at The Children's Hospital of Philadelphia . Promising new agents for treatment of patients with colorectal cancer.
Colorectal cancer continues to be a major problem.
There are a number of new agents with promising clinical activity, including the multitargeted antifolate LY 231514 and the thymidylate synthesis inhibitor capecitabine. PDQ statements exist for a number of topics. Please consult the PDQ Index . The information provided through OncoLink should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care.